5-Fluorouracil loaded magnetic cellulose bionanocomposites for potential colorectal cancer treatment

被引:49
|
作者
Yusefi, Mostafa [1 ]
Lee-Kiun, Michiele Soon [2 ]
Shameli, Kamyar [1 ]
Teow, Sin-Yeang [2 ]
Ali, Roshafima Rasit [1 ]
Siew, Kit-Kim [3 ]
Chan, Hui-Yin [2 ]
Wong, Magdelyn Mei-Theng [2 ]
Lim, Wei-Ling [3 ]
Kuca, Kamil [1 ,4 ]
机构
[1] Univ Teknol Malaysia, Malaysia Japan Int Inst Technol, Jalan Sultan Yahya Petra, Kuala Lumpur 54100, Malaysia
[2] Sunway Univ, Sch Med & Life Sci, Dept Med Sci, Jalan Univ, Bandar Sunway 47500, Selangor Darul, Malaysia
[3] Sunway Univ, Sch Med & Life Sci, Dept Biol Sci, Jalan Bandar Sunway, Selangor Darul Ehsan 47500, Malaysia
[4] Univ Hradec Kralove, Fac Sci, Dept Chem, Hradec Kralove, Czech Republic
关键词
Cellulose; Fe3O4-nanoparticles; Composites; 5-Fluorouracil; Drug carrier system; Colorectal cancer; Microfluidic; Co-culture; TARGETED DRUG-DELIVERY; OXIDE NANOPARTICLES; FIBERS; RICE;
D O I
10.1016/j.carbpol.2021.118523
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Magnetic polymer nanocomposites are inherently multifunctional and harbor assorted physiochemical actions for applications thereof as novel drug nanocarriers. Herein, Fe3O4-nanoparticles were supported on rice straw cellulose for 5-fluorouracil carrier abbreviated as MC/5-FU for potential colorectal cancer treatments. Several analyses indicated the multifunctional properties of MC/5-FU bionanocomposites. Transmission and scanning electron microscopy study demonstrated that Fe3O4 nanofillers covered the cellulose matrix. The drug release from MC/5-FU was evaluated under various pH and temperature conditions, showing the maximum release at pH 7.4 and 44.2 degrees C. In in vitro anticancer assay, MC/5-FU exhibited enhanced selectivity and anticancer actions against 2D monolayer and 3D tumour spheroid models colorectal cancer cells. The anticancer effects of MC/5-FU with magnetic targeting and heat induction were also examined. This easily synthesized MC/5-FU indicated the potential in application as a low-cost drug formulation for colorectal cancer treatments.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Development and Characterization of 5-Fluorouracil Solid Lipid Nanoparticles for Treatment of Colorectal Cancer
    Poournima Patil
    Suresh Killedar
    Harinath More
    Ganesh Vambhurkar
    Journal of Pharmaceutical Innovation, 2022, 17 : 1268 - 1281
  • [32] Capecitabine in the treatment of metastatic colorectal cancer refractory to 5-fluorouracil chemotherapy.
    Salek, T
    Mardiak, J
    Mego, M
    Hlavata, Z
    Obertova, J
    Sycova-Mila, Z
    Minarik, T
    Sufliarsky, J
    Bohunicky, L
    Thalmeinerova, Z
    Koza, I
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 293S - 293S
  • [33] TREATMENT OF COLORECTAL-CANCER AND OTHER MALIGNANCIES WITH CONTINUOUS INFUSION OF 5-FLUOROURACIL
    BARBOUNIS, VP
    KALOFONOS, HP
    MUNRO, AJ
    MCKENZIE, CG
    SACKIER, JM
    EPENETOS, AA
    ANTICANCER RESEARCH, 1989, 9 (01) : 33 - 39
  • [34] TREATMENT OF METASTATIC COLORECTAL CARCINOMA WITH 5-FLUOROURACIL BY MOUTH
    LAHIRI, SR
    BOILEAU, G
    HALL, TC
    CANCER, 1971, 28 (04) : 902 - &
  • [35] Beyond 5-fluorouracil monochemotherapy in colorectal cancer - It is time
    Satta, F
    Franchi, F
    JOURNAL OF CHEMOTHERAPY, 1997, 9 (06) : 431 - 435
  • [36] Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer
    Fioravanti, Anna
    Canu, Bastianina
    Ali, Greta
    Orlandi, Paola
    Allegrini, Giacomo
    Di Desidero, Teresa
    Emrilenegger, Urban
    Fontanini, Gabriella
    Danesi, Romano
    Del Tacca, Mario
    Falcone, Alfredo
    Bocci, Guido
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 619 (1-3) : 8 - 14
  • [37] Upregulation of enzymes metabolizing 5-fluorouracil in colorectal cancer
    Matsusaka, Satoshi
    Yamasaki, Hajime
    Fukushima, Masakazu
    Wakabayashi, Ichiro
    CHEMOTHERAPY, 2007, 53 (01) : 36 - 41
  • [38] Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
    Xie, Pan
    Mo, Jun-Luan
    Liu, Jin-Hong
    Li, Xi
    Tan, Li-Ming
    Zhang, Wei
    Zhou, Hong-Hao
    Liu, Zhao-Qian
    CELLULAR ONCOLOGY, 2020, 43 (06) : 989 - 1001
  • [39] Pathways of oxaliplatin/5-fluorouracil resistance in colorectal cancer
    Turkington, R.
    Allen, W.
    Stevenson, L.
    Coyle, V.
    Jithesh, P.
    Proutski, I.
    Fenning, C.
    Stewart, G.
    Longley, D.
    Johnston, P.
    EJC SUPPLEMENTS, 2009, 7 (02): : 342 - 342
  • [40] 5-Fluorouracil in colorectal cancer, a never ending story
    Herrmann, R
    ANNALS OF ONCOLOGY, 1996, 7 (06) : 551 - 552